Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 3/6 |
Nanjing Medlander Medical Technology Co.,Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥19.55 |
52 Week High | CN¥40.12 |
52 Week Low | CN¥17.64 |
Beta | 0 |
11 Month Change | 1.03% |
3 Month Change | -21.49% |
1 Year Change | -41.17% |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -55.64% |
Recent News & Updates
Shareholder Returns
688273 | CN Medical Equipment | CN Market | |
---|---|---|---|
7D | 1.7% | 0.4% | -1.6% |
1Y | -41.2% | -15.2% | -19.6% |
Return vs Industry: 688273 underperformed the CN Medical Equipment industry which returned -14.8% over the past year.
Return vs Market: 688273 underperformed the CN Market which returned -20.8% over the past year.
Price Volatility
688273 volatility | |
---|---|
688273 Average Weekly Movement | 5.7% |
Medical Equipment Industry Average Movement | 5.1% |
Market Average Movement | 5.7% |
10% most volatile stocks in CN Market | 9.0% |
10% least volatile stocks in CN Market | 3.8% |
Stable Share Price: 688273's share price has been volatile over the past 3 months.
Volatility Over Time: 688273's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2013 | 481 | n/a | www.medlander.com |
Nanjing Medlander Medical Technology Co.,Ltd. engages in the research and development, and supply of pelvic floor rehabilitation equipment and clinical solutions in China. The company offers pelvic floor and obstetrics and gynecology rehabilitation, reproductive rehabilitation product, and sports rehabilitation products, as well as consumables products, such as vaginal electrodes, rectal electrodes, vaginal probes, etc. It also provides pelvic floor muscle rehabilitation devices, biological feedback and stimulation systems, biological stimulation feedback portable instruments, matching consumables/accessories, and ultrasonic uterine involution instruments, as well as information software for grading diagnosis and treatment of pelvic floor diseases.
Nanjing Medlander Medical Technology Co.,Ltd. Fundamentals Summary
688273 fundamental statistics | |
---|---|
Market cap | CN¥1.93b |
Earnings (TTM) | CN¥93.72m |
Revenue (TTM) | CN¥336.04m |
20.6x
P/E Ratio5.8x
P/S RatioIs 688273 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
688273 income statement (TTM) | |
---|---|
Revenue | CN¥336.04m |
Cost of Revenue | CN¥85.75m |
Gross Profit | CN¥250.28m |
Other Expenses | CN¥156.57m |
Earnings | CN¥93.72m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 22, 2024
Earnings per share (EPS) | 0.95 |
Gross Margin | 74.48% |
Net Profit Margin | 27.89% |
Debt/Equity Ratio | 0.5% |
How did 688273 perform over the long term?
See historical performance and comparison